Related Experiment Video
Updated: May 1, 2026
High-throughput Detection Method for Influenza Virus
Published on: February 4, 2012
Full Genome Analysis of Influenza A(H1N1)pdm09 Virus Isolated from Peru, 2013
Carlos Padilla1, Fredy Condori, Maribel Huaringa
1Biotechnology and Molecular Biology Laboratory, Instituto Nacional de Salud, Lima, Peru.
Abstract:
The pandemic influenza A(H1N1)pdm09 virus has been reported in Peru since 2009. We report the whole-genome sequence analysis of a viral isolate from an infection case that occurred during an influenza outbreak in 2013. This strain shows novel hemagglutinin (HA) mutations that may cause an antigenic drift that diminishes the protective effect of the vaccine.
Insights
The 2013 influenza A(H1N1)pdm09 virus in Peru showed new hemagglutinin mutations. These changes may reduce vaccine effectiveness due to antigenic drift.
Area of Science:
- Virology
- Genomic sequencing
- Epidemiology
Background:
- Influenza A(H1N1)pdm09 virus has circulated in Peru since 2009.
- Influenza outbreaks pose a continuous public health challenge.
Purpose of the Study:
- To analyze the whole-genome sequence of an influenza A(H1N1)pdm09 viral isolate from a 2013 outbreak in Peru.
- To identify genetic mutations that could impact viral properties and vaccine efficacy.
Main Methods:
- Whole-genome sequencing of the influenza A(H1N1)pdm09 virus.
- Bioinformatic analysis of the viral genome, focusing on hemagglutinin (HA) mutations.
Main Results:
- The 2013 viral isolate possessed novel hemagglutinin (HA) mutations.
- These mutations suggest a potential for antigenic drift in the circulating influenza strain.
Conclusions:
- The identified HA mutations may lead to reduced protection from current influenza vaccines.
- Continuous genomic surveillance is crucial for monitoring influenza evolution and vaccine strain selection in Peru.
